Nebulized Morphine in Chest Trauma Patients: A Prospective Study

• Status: Completed
• Trial end date: 2019-12-30
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective study carried out from 2014 to 2016 including patients aged ≥ 18 years, admitted for isolated chest trauma. Each patient received a nebulization of 10 mg morphine. If Visual Analog Score (VAS) assessed after 10 minutes still> 4, nebulization was repeated every 10 minutes until pain relief. At 30 minutes, VAS> 4 means failure.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Mahdia
• Treatments: Morphine

Criteria

Inclusion Criteria:

• patients aged 18 years and over

• victims of isolated chest trauma,

• admitted to the intensive care unit

Exclusion Criteria:

• not consen

• pregnant woman

• polytrauma

• hemodynamic instability with systolic blood pressure less than 100 mmHg,

• treated with morphine during transport or in the emergency room

• need initial ventilatory support, bradypnea (respiratory rate less than 12 cycles per minute)

• allergy to opiods

• initial pain Visual Analog Scale (VAS) ≤ 4